Enovis Corporation

NYSE (USD): Enovis Corporation (ENOV)

Last Price

46.90

Today's Change

+3.59 (8.28%)

Day's Change

46.20 - 49.83

Trading Volume

1,519,339

Profile
ENOV

Exchange:  New York Stock Exchange New York Stock Exchange

Currency:  USD USD

Sector:  Industrials - Industrials Industrials - Industrials

Industry: 

CEO:  Mr. Matthew L. Trerotola Mr. Matthew L. Trerotola

Full Time Employees:  6,550 6,550

IPO Date:  2008-05-08 2008-05-08

CIK:  0001420800 0001420800

ISIN:  US1940145022 US1940145022

CUSIP:  194014502 194014502

Beta:  2.00 2.00

Last Dividend:  0.00 0.00

Dcf Diff:  54.38 54.38

Dcf:  -7.80 -7.80

Description

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

Address

2711 Centerville Road,
Wilmington, DE 19808, US

302 252 9190

http://www.enovis.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment